Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

MPL mutations in essential thrombocythemia uncover a common path of activation with eltrombopag dependent on W491

Gabriel Levy, Serge Carillo, Benjamin Papoular, Bruno Cassinat, Jean-Marc Zini, Emilie Leroy, Leila N. Varghese, Ilyas Chachoua, Jean-Philippe Defour, Steven O. Smith, Stefan N. Constantinescu

Blood (2020) 135 (12): 948–953.

https://doi.org/10.1182/blood.2019003240

Published: 2020

Includes: Supplemental data

Journal Articles

Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations

Emmanuelle Verger, Bruno Cassinat, Aurélie Chauveau, Christine Dosquet, Stephane Giraudier, Marie-Hélène Schlageter, Jean-Christophe Ianotto, Mohammed A. Yassin, Nader Al-Dewik, Serge Carillo, Eric Legouffe, Valerie Ugo, Christine Chomienne, Jean-Jacques Kiladjian

Blood (2015) 126 (24): 2585–2591.

https://doi.org/10.1182/blood-2015-07-659060

Published: 2015

Journal Articles

In Vitro Functional Rescue of a Double MPL K39N/W272R Mutant Associated with Congenital Amegakaryocytic Thrombocytopenia (CAMT) Using Crispr/Cas9

Cédric Cleyrat, PhD, Romain Girard, M.S., Éric Jeziorski, MD, Thierry Lavabre-Bertrand, PhD, Sylvie Hermouet, MD, PhD, Serge Carillo, PhD, Bridget S. Wilson, PhD

Blood (2015) 126 (23): 1207.

https://doi.org/10.1182/blood.V126.23.1207.1207

Published: 2015

Journal Articles

Presence of calreticulin mutations in JAK2 -negative polycythemia vera

Julien Broséus, Ji-Hye Park, Serge Carillo, Sylvie Hermouet, François Girodon

Blood (2014) 124 (26): 3964–3966.

https://doi.org/10.1182/blood-2014-06-583161

Published: 2014

Journal Articles

Impact of the Molecular Profile of Malignant Clones on the Response to Interferon Alpha (IFNa) Therapy in JAK2V617F-Negative Essential Thrombocythemia (ET)

Emmanuelle Verger, PhD, Bruno Cassinat, PharmD, PhD, Christine Dosquet, MD PhD, Marie-Helene Schlageter, Valérie Ugo, MD PhD, Jean-Christophe Ianotto, MD, Mohamed A. Yassin, MBBS ,MSc,CABM,FACP, Nader Dewik, PhD, Serge Carillo, PhD, Christine Chomienne, MD PhD, Jean-Jacques Kiladjian, MD PhD

Blood (2014) 124 (21): 407.

https://doi.org/10.1182/blood.V124.21.407.407

Published: 2014

Journal Articles

Presence of Calreticulin Mutations in JAK2 -Negative Polycythemia Vera

Francois Girodon, MD PhD, Julien Broseus, Ji-Hye Park-Alexandre, Sylvie Hermouet, MD, PhD, Serge Carillo, PhD

Blood (2014) 124 (21): 1819.

https://doi.org/10.1182/blood.V124.21.1819.1819

Published: 2014

Journal Articles

JAK2 Exon 12 Mutant Allele Burden Study (JETMABS): A European Multicenter Study

Lasse Kjaer, Ph.D., Eric Lippert, Francois Girodon, MD, PhD, Susanne Schnittger, PhD, Serge Carillo, Caroline Riley, MD, Beatriz Bellosillo, Maj K. Westman, Ole Weis Bjerrum, MD, Marzena Wojtaszewska, Thomas Kristensen, MSc, PhD, Melanie Percy, PhD, Mary Frances McMullin, MD, MRCPath, Maruska Marusic, Caroline Rosmond, Lars Palmqvist, MD, PhD, Sylvie Hermouet, MD, Ph.D., Hans Carl Hasselbalch, MD, DMSc

Blood (2013) 122 (21): 4075.

https://doi.org/10.1182/blood.V122.21.4075.4075

Published: 2013

Journal Articles

High-Resolution Melting (HRM) Curve Analysis Is a Reliable and Relevant Tool In JAK2 V617F-Negative Myeloproliferative Neoplasms

Francois Girodon, MD, PhD, Eric Lippert, Sylvie Hermouet, MD, Ph.D., Serge Carillo, PhD

Blood (2013) 122 (21): 4077.

https://doi.org/10.1182/blood.V122.21.4077.4077

Published: 2013

Journal Articles

Interlaboratory Quality Control Round of MPL Mutation Detection in Fourteen European Laboratories: A MPN&MPNr-EuroNet Study,

Naomi A. Porret, PhD, Elisabeth Oppliger Leibundgut, PharmD, Serge Carillo, Bruno Cassinat, PharmD, Francois Girodon, MD, PhD, Éric Lippert, MD, PhD, Valérie Ugo, MD, PhD, Sylvie Hermouet, MD, PhD, Paola Guglielmelli, MD, Jiri Schwarz, MD, PhD, Beatriz Bellosillo, Susanne Schnittger, PhD, Maj K. Westman, Stephane Giraudier, MD, PhD

Blood (2011) 118 (21): 3859.

https://doi.org/10.1182/blood.V118.21.3859.3859

Published: 2011

Journal Articles

First Achievements of MPN&MPNr-EuroNet (COST Action BM0902), a New European Network Dedicated to the Diagnosis of Myeloproliferative Neoplasms and Hereditary Erythrocytosis and Thrombocytosis

Sylvie Hermouet, MD, PhD, Eric Lippert, PhD, Niels Pallisgaard, Jiri Schwarz, MD, PhD, Mary Frances McMullin, MD, Lars Palmqvist, MD, PhD, Heike L Pahl, Ph.D., Beatriz Bellosillo Paricio, Celeste Bento, Serge Carillo, Stephane Giraudier, MD, PhD, Francois Girodon, MD, PhD, Melanie Percy, PhD, FRCPath, Lukas Plank, Susanne Schnittger, PhD, Radek C. Skoda, MD, Alessandro M. Vannucchi, MD

Blood (2011) 118 (21): 2809.

https://doi.org/10.1182/blood.V118.21.2809.2809

Published: 2011

Journal Articles

Concordance of Assays Designed for the Quantitation of JAK2 1849G>T (V617F): A Multi-Centre Study.

Eric Lippert, François Girodon, Emma Hammond, Serge Carillo, Céline Richard, Boris Fehse, Mirjam Hermans, Ian James, Jaroslav Jelinek, Christophe Marzac, Marina Migeon, Daniela Pietra, Josef T. Prchal, N. Scott Reading, Marta Sobas, Valérie Ugo, Radek C. Skoda, Sylvie Hermouet

Blood (2007) 110 (11): 2529.

https://doi.org/10.1182/blood.V110.11.2529.2529

Published: 2007

NARROW

MPL mutations in essential thrombocythemia uncover a common path of activation with eltrombopag dependent on W491

Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations

In Vitro Functional Rescue of a Double MPL K39N/W272R Mutant Associated with Congenital Amegakaryocytic Thrombocytopenia (CAMT) Using Crispr/Cas9

Presence of calreticulin mutations in JAK2 -negative polycythemia vera

Impact of the Molecular Profile of Malignant Clones on the Response to Interferon Alpha (IFNa) Therapy in JAK2V617F-Negative Essential Thrombocythemia (ET)

Presence of Calreticulin Mutations in JAK2 -Negative Polycythemia Vera

JAK2 Exon 12 Mutant Allele Burden Study (JETMABS): A European Multicenter Study

High-Resolution Melting (HRM) Curve Analysis Is a Reliable and Relevant Tool In JAK2 V617F-Negative Myeloproliferative Neoplasms

Interlaboratory Quality Control Round of MPL Mutation Detection in Fourteen European Laboratories: A MPN&MPNr-EuroNet Study,

First Achievements of MPN&MPNr-EuroNet (COST Action BM0902), a New European Network Dedicated to the Diagnosis of Myeloproliferative Neoplasms and Hereditary Erythrocytosis and Thrombocytosis

Concordance of Assays Designed for the Quantitation of JAK2 1849G>T (V617F): A Multi-Centre Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only